– USA, MA – EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the eye, today announced that Steven Boyd has joined its board.… => Read full post